Neuro-Oncology Reviews
Volume
25 Number 12
30 June 2023
Home > Publications > Neuro-Oncology Reviews > Volume 25, Year 2023 > Number 12, 30 June
Chan P, Rich JN, Kay SA.
Watching the
Clock in Glioblastoma.
Neuro Oncol. 2023 Jun
16:noad107∟.
doi: 10.1093/neuonc/noad107∟.
PMID: 37326042∟.
Review. ˍ
Grønbæk JK, Boeg Thomsen D, Persson K, Mathiasen R,
Juhler M.
The Cerebellar Mutism
Syndrome: Risk Assessment, Prevention and Treatment.
Adv
Tech Stand Neurosurg. 2023 Jun 16;46:65-94∟.
doi: 10.1007/978-3-031-28202-7_4∟.
PMID: 37318570∟.
Review,
Book chapter˰ ˍ
Mijderwijk HJ.
Evolution of Making
Clinical Predictions in Neurosurgery.
Adv
Tech Stand Neurosurg. 2023 Jun 16;46:109-123∟.
doi: 10.1007/978-3-031-28202-7_6∟.
PMID: 37318572∟.
Review,
Book chapter˰ ˍ
Miller DC.
The World Health
Organization Classification of Tumors of the Central Nervous
System, Fifth Edition, 2021: A Critical Analysis.
Adv
Tech Stand Neurosurg. 2023 Jun 16;46:1-21∟.
doi: 10.1007/978-3-031-28202-7_1∟.
PMID: 37318567∟.
Review,
Book chapter˰ ˍ
Salomão JFM, Protzenko T.
Intracranial
Tumors in the First Year of Life.
Adv Tech
Stand Neurosurg. 2023 Jun 16;46:23-52∟.
doi: 10.1007/978-3-031-28202-7_2∟.
PMID: 37318568∟.
Review, Book chapter˰ ˍ
Spina S, Facciorusso S, Cinone N, Pellegrino R, Fiore P, Santamato
A.
Rehabilitation interventions for
glioma patients: a mini-review.
Front
Surg. 2023 Jun 16;10:1137516∟.
doi: 10.3389/fsurg.2023.1137516∟.
PMID: 37396290∟.
Review. ˍ
Karkon-Shayan S, Aliashrafzadeh H, Dianat-Moghadam H,
Rastegar-Pouyani N, Majidi M, Zarei M, Moradi-Vastegani S,
Bahramvand Y, Babaniamansour S, Jafarzadeh E.
Resveratrol
as an antitumor agent for glioblastoma multiforme: Targeting
resistance and promoting apoptotic cell deaths.
Acta
Histochem. 2023 Jun 17;125(6):152058∟.
doi: 10.1016/j.acthis.2023.152058∟.
PMID: 37336070∟.
Review˰ ˍ
Nowak M, Górczyńska J, Kołodzińska K, Rubin
J, Choromańska A.
Extracellular
Vesicles as Drug Transporters.
Int
J Mol Sci. 2023 Jun 17;24(12):10267∟.
doi: 10.3390/ijms241210267∟.
PMID: 37373411∟.
Review.
ˍ
Zhang SP, He C, Wang XP, Wang B,
Tang ZW.
Case
report of epileptic seizure during awake craniotomy of functional
area glioma and literature study.
Int
Rev Neurobiol. 2023 Jun 17;172:321-331∟.
doi: 10.1016/bs.irn.2023.05.016∟.
PMID: 37833017∟.
Case report, Review. ˍ
Ji X, Ding W, Wang J, Zhou B, Li Y, Jiang W, Pan H, Gu J, Sun
X.
Application of intraoperative
radiotherapy for malignant glioma.
Cancer
Radiother. 2023 Jun 19:S1278-3218(23)00066-5∟.
doi: 10.1016/j.canrad.2023.01.007∟.
PMID: 37344258∟.
Review˰ ˍ
Kehoe K, Sivaguru H, Coulter I, Cowie C.
Delay
in the diagnosis of paediatric brain tumours: a systematic
review.
Childs Nerv
Syst. 2023 Jun 19∟.
doi: 10.1007/s00381-023-06022-y∟.
PMID: 37336792∟.
Review˰ ˍ
Mendez Valdez MJ, Kim E, Bhatia S, Saad AG, Sidani C, Daggubati L,
Chandar J, Seetharam D, Desgraves J, Ingle S, Luther E, Ivan M,
Komotar R, Shah AH.
Outcomes of HSV-1
encephalitis infection in glioblastoma: An integrated systematic
analysis.
Microb
Pathog. 2023 Jun 19:106211∟.
doi: 10.1016/j.micpath.2023.106211∟.
PMID: 37343897∟.
Meta-analysis˰
ˍ
Xiong Q, Zhu J, Zhang Y, Deng H.
CAR-NK
cell therapy for glioblastoma: what to do next?
Front
Oncol. 2023 Jun 19;13:1192128∟.
doi: 10.3389/fonc.2023.1192128∟.
PMID: 37404752∟.
Review. ˍ
Zhong J, Lu J, Zhang G, Mao S, Chen H, Yin Q, Hu Y, Xing Y, Ding
D, Ge X, Zhang H, Yao W.
An overview of
meta-analyses on radiomics: more evidence is needed to support
clinical translation.
Insights Imaging. 2023 Jun
19;14(1):111∟.
doi: 10.1186/s13244-023-01437-2∟.
PMID: 37336830∟.
Review. ˍ
Wang J, Liu Y, Liu F, Gan S, Roy S, Hasan I, Zhang B, Guo
B.
Emerging extracellular vesicle-based
carriers for glioblastoma diagnosis and therapy.
Nanoscale.
2023 Jun 20∟.
doi: 10.1039/d3nr01667f∟.
PMID: 37337814∟.
Review˰ ˍ
Yoshikawa MH, Rabelo NN, Telles JPM, Figueiredo EG.
Modifiable
risk factors for glioblastoma: a systematic review and
meta-analysis.
Neurosurg
Rev. 2023 Jun 20;46(1):143∟.
doi: 10.1007/s10143-023-02051-y∟.
PMID: 37340151∟.
Review, Meta-analysis˰ ˍ
Huo H, Shen S, Yang Y, Zhang H, Wu S, Bi T, Li Y.
The
risk of intracranial hemorrhage in glioma patients receiving
anticoagulant treatment for venous thromboembolism: a bayesian
network meta-analysis.
J
Thromb Thrombolysis. 2023 Jun 21∟.
doi: 10.1007/s11239-023-02851-5∟.
PMID: 37341895∟.
Meta-analysis˰ ˍ
Muzyka L, Goff NK, Choudhary N, Koltz MT.
Systematic
Review of Molecular Targeted Therapies for Adult-Type Diffuse
Glioma: An Analysis of Clinical and Laboratory Studies.
Int
J Mol Sci. 2023 Jun 21;24(13):10456∟.
doi: 10.3390/ijms241310456∟.
PMID: 37445633∟.
Review. ˍ
Wala JA, Hanna GJ.
Chimeric Antigen
Receptor T-Cell Therapy for Solid Tumors.
Hematol
Oncol Clin North Am. 2023 Jun 21:S0889-8588(23)00064-3∟.
doi: 10.1016/j.hoc.2023.05.009∟.
PMID: 37353377∟.
Review˰ ˍ
Soldozy S, Eichberg DG, Morell AA, Luther E, Lu VM, Higgins DMO,
Patel NV, Shah AH, Hanft SJ, Komotar RJ, Ivan ME.
Oncolytic
Virotherapy for High-Grade Glioma and Current Evidence and Factors
to Consider for Incorporation into Clinical Practice.
Pathogens.
2023 Jun 22;12(7):861∟.
doi: 10.3390/pathogens12070861∟.
PMID: 37513708∟.
Review. ˍ
Vuu YM, Kadar Shahib A, Rastegar M.
The
Potential Therapeutic Application of Simvastatin for Brain
Complications and Mechanisms of Action.
Pharmaceuticals
(Basel). 2023 Jun 22;16(7):914∟.
doi: 10.3390/ph16070914∟.
PMID: 37513826∟.
Review. ˍ
Das S, Dash BS, Premji TP, Chen JP.
Immunotherapeutic
Approaches for the Treatment of Glioblastoma Multiforme: Mechanism
and Clinical Applications.
Int
J Mol Sci. 2023 Jun 23;24(13):10546∟.
doi: 10.3390/ijms241310546∟.
PMID: 37445721∟.
Review. ˍ
Hassanipour S, Nikbakht HA, Amrane A, Arab-Zozani M, Shojaie L,
Rostami S, Badeenezhad A.
The
Relationship between Air Pollution and Brain Cancer: A Systematic
Review and Meta-Analysis.
Ann
Glob Health. 2023 Jun 23;89(1):45∟.
doi: 10.5334/aogh.3889∟.
PMID: 37362828∟.
Review, Meta-analysis. ˍ
Vanbilloen WJF, Rechberger JS, Anderson JB, Nonnenbroich LF, Zhang
L, Daniels DJ.
Nanoparticle Strategies
to Improve the Delivery of Anticancer Drugs across the Blood-Brain
Barrier to Treat Brain Tumors.
Pharmaceutics.
2023 Jun 23;15(7):1804∟.
doi: 10.3390/pharmaceutics15071804∟.
PMID: 37513992∟.
Review. ˍ
Boylan J, Byers E, Kelly DF.
The
Glioblastoma Landscape: Hallmarks of Disease, Therapeutic
Resistance, and Treatment Opportunities.
Med
Res Arch. 2023 Jun 26;11(6):10.18103/mra.v11i6.3994∟.
doi: 10.18103/mra.v11i6.3994∟.
PMID: 38107346∟.
Review. ˍ
Kim YM, Kitlinska JB.
Editorial: Women
in pediatric oncology Vol II: 2022.
Front
Oncol. 2023 Jun 26;13:1223296∟.
doi: 10.3389/fonc.2023.1223296∟.
PMID: 37434976∟.
Editorial. ˍ
Jumapili NA, Zivalj M, Barthelmess RM, Raes G, De Groof TWM,
Devoogdt N, Stijlemans B, Vincke C, Van Ginderachter JA.
A
few good reasons to use nanobodies for cancer treatment.
Eur
J Immunol. 2023 Jun 27:e2250024∟.
doi: 10.1002/eji.202250024∟.
PMID: 37366246∟.
Review.
ˍ
Boltman T, Meyer M, Ekpo O.
Diagnostic
and Therapeutic Approaches for Glioblastoma and Neuroblastoma
Cancers Using Chlorotoxin Nanoparticles.
Cancers
(Basel). 2023 Jun 28;15(13):3388∟.
doi: 10.3390/cancers15133388∟.
PMID: 37444498∟.
Review. ˍ
Larsen PA, Amidi A, Ghith N, Winther JF, Pedersen C.
Quality
of life of adolescent and adult survivors of childhood cancer in
Europe-A systematic review.
Int
J Cancer. 2023 Jun 28∟.
doi: 10.1002/ijc.34634∟.
PMID: 37377041∟.
Review. ˍ
Ragucci F, Sireci F, Cavallieri F, Rossi J, Biagini G, Tosi G,
Lucchi C, Molina-Pena R, Ferreira NH, Zarur M, Ferreiros A,
Bourgeois W, Berger F, Abal M, Rousseau A, Boury F,
Alvarez-Lorenzo C, Garcion E, Pisanello A, Pavesi G, Iaccarino C,
Ghirotto L, Bassi MC, Valzania F.
Insights
into Healthcare Professionals' Perceptions and Attitudes toward
Nanotechnological Device Application: What Is the Current
Situation in Glioblastoma Research?
Biomedicines. 2023
Jun 28;11(7):1854∟.
doi: 10.3390/biomedicines11071854∟.
PMID: 37509494∟.
Review. ˍ
Tosi U, Souweidane M.
Fifty years of
DIPG: looking at the future with hope.
Childs
Nerv Syst. 2023 Jun 29∟.
doi: 10.1007/s00381-023-06037-5∟.
PMID: 37382660∟.
Review˰ ˍ
Bhanja D, Wilding H, Baroz A, Trifoi M, Shenoy G, Slagle-Webb B,
Hayes D, Soudagar Y, Connor J, Mansouri A.
Photodynamic
Therapy for Glioblastoma: Illuminating the Path toward Clinical
Applicability.
Cancers
(Basel). 2023 Jun 30;15(13):3427∟.
doi: 10.3390/cancers15133427∟.
PMID: 37444537∟.
Review. ˍ
Halawa T, Baeesa S, Fadul MM, Badahdah AA, Enani M, Fathaddin AA,
Kawass D, Alkhotani A, Bahakeem B, Kurdi M.
The
Role of Liquid Biopsy in the Diagnosis and Prognosis of WHO Grade
4 Astrocytoma.
Cureus.
2023 Jun 30;15(6):e41221∟.
doi: 10.7759/cureus.41221∟.
PMID: 37525780∟.
Review. ˍ
Li W, Xu X.
Advances in mitophagy and
mitochondrial apoptosis pathway-related drugs in glioblastoma
treatment.
Front
Pharmacol. 2023 Jun 30;14:1211719∟.
doi: 10.3389/fphar.2023.1211719∟.
PMID: 37456742∟.
Review. ˍ
*
Pu Y, Zhou G, Zhao K, Chen Y, Shen S.
Immunotherapy
for Recurrent Glioma-From Bench to Bedside.
Cancers
(Basel). 2023 Jun 30;15(13):3421∟.
doi: 10.3390/cancers15133421∟.
PMID: 37444531∟.
Review. ˍ
Rubiano EGO, Baldoncini M, Cómbita AL, Payán-Gómez
C, Gómez-Amarillo DF, Hakim F, Figueredo LF, Forlizzi V,
Rangel CC, Luzzi S, Campero A, Parra-Medina R.
Understanding
the molecular profiling of diffuse gliomas classification: A brief
overview.
Surg Neurol
Int. 2023 Jun 30;14:225∟.
doi: 10.25259/SNI_209_2023∟.
PMID: 37404501∟.
Review. ˍ